This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RAD51C Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAD51C WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~42.2 kDa | |
| Observed band | ~42 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated | |
| Caveat | Alternative splicing isoforms | |
| Regulation | p53 up | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for RAD51C — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Hela , Lane 2: human 293T , Lane 3: human A549 , Lane 4: rat testis . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-RAD51C antigen affinity purified polyclonal antibody (Catalog # A01837-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for RAD51C at approximately 42 kDa. The expected band size for RAD51C is at 42 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 42 kDa |
RAD51C has a 42.2 kDa predicted backbone and runs at the matching ~42 kDa observed band, since it lacks glycosylation and disulfide-linked oligomerization that would shift its size.
| single sharp band at ~42 kDa | matches the 42.2 kDa predicted mass, consistent with a protein carrying no glycosylation, disulfide bonds, or cleavable signal/propeptide sequence |
| band unchanged between reducing and non-reducing sample buffer | RAD51C has no inter-chain disulfide bonds, so there is no shift to a higher-mass covalent dimer under non-reducing conditions |
| band still runs at ~42 kDa monomer size even from lysates where RAD51C is complexed with other RAD51 paralogs | participation in the non-covalent BCDX2 and CX3 paralog complexes is disrupted by SDS and heat, so the protein resolves as a monomer rather than a high-molecular-weight complex band |
| faint second band close to the main ~42 kDa band | alternative splicing produces isoform 2 in addition to canonical isoform 1, which can appear as a closely spaced or minor additional band |
| slight upward smear or doublet around the main band | phosphorylation at Ser20 can create a small population of protein migrating marginally slower than the unmodified species |
| band present in both nuclear-enriched and whole-cell lysate fractions at the same size | RAD51C localizes to nucleus, cytoplasm, and mitochondrion without size-altering compartment-specific processing |
| predicted mass (42.2 kDa) | sets the baseline expected migration, closely matched by the empirical ~42 kDa observed band |
| absence of glycosylation | no added carbohydrate mass, so the band stays near the predicted size rather than running higher or smearing |
| absence of disulfide bonds | protein migrates as a ~42 kDa monomer on both reducing and non-reducing gels, with no shift to an ~84 kDa dimer band |
| non-covalent BCDX2/CX3 complex membership | complex is dissociated by SDS and reducing/denaturing conditions, so the protein still runs as a single monomer band despite assembling into multi-subunit complexes in vivo |
| alternative splicing (isoforms 1 and 2) | canonical isoform 1 and shorter isoform 2 can each contribute a band, with isoform 2 expected to run somewhat differently without an exact assigned kDa |
| Ser20 phosphorylation | phosphorylated fraction can migrate marginally slower than the unmodified species, adding subtle heterogeneity around the main band |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | Ser20 phosphorylation or incomplete denaturation of paralog-complex-associated RAD51C | ensure complete sample denaturation with fresh reducing sample buffer and sufficient boiling, and use a phosphatase-treated control lane if a shift is suspected |
| Weak or no signal | RAD51C is a low-abundance nuclear DNA repair protein whose levels rise after DNA damage | treat cells with a genotoxic agent to induce expression, load more total protein, and use a nuclear-enriched extraction protocol |
| Multiple bands | detection of both splice isoforms 1 and 2, or degradation of the low-abundance protein | compare band pattern to isoform sequences and antibody epitope location, and add protease inhibitors to rule out degradation |
| Band lower than expected | proteolytic degradation of this low-abundance, DNA-damage-responsive protein during lysis | use fresh lysates with protease inhibitors and minimize sample handling and freeze-thaw cycles |
| No band in lysate | cytoplasm-only lysis protocols can under-recover RAD51C, which is concentrated in the nucleus and mitochondrion | use a whole-cell or nuclear/mitochondrial extraction protocol that efficiently solubilizes these compartments |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for RAD51C, answered from its protein features.
BosterBio's RAD51C antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Boster's anti-RAD51C antibodies are top-performing, extensively cited Western blot reagents, rigorously validated and orthogonally cross-checked against negative-tissue controls and complementary detection methods, giving researchers confident, reproducible RAD51C detection for their experiments.
Which to pick: Two options are listed: A01837-1 and PB9792, each with a genuine RAD51C Western blot validation image. No species or additional differentiating data is provided, so either is a reasonable starting choice; compare the published blot images to your sample before deciding.